Results 41 to 50 of about 376,110 (130)

Technical Note: Novel Use of CytoSorb™ Haemadsorption to Provide Wound Healing Support in Case of Severe Burn Trauma via Reduction of Hyperbilirubinaemia

Frontiers in Surgery, 2021
Hyperbilirubinaemia has been shown to compromise wound healing in severely burned patients. The therapy options for patients with impairment of wound healing and subsequent severe liver dysfunction are limited. A novel extracorporeal treatment, CytoSorb®
Katarzyna Rachunek, Maja Krause, Johannes Tobias Thiel, Jonas Kolbenschlag, Adrien Daigeler, Andreas Bury   +5 more
doaj   +1 more source

Post VV-ECMO Weaning Hyperinflammation—Can Prophylactic Hemoadsorption Treatment Prevent Complications?

Medicina, 2023
Acute respiratory distress syndrome (ARDS) is a severe clinical condition characterized by acute respiratory failure and a high mortality risk despite conventional mechanical ventilatory support.
Pedja Kovacevic, Sasa Dragic, Milka Jandric, Danica Momcicevic, Sandra Topolovac, Vedrana Malesevic, Tijana Kovacevic, Marijana Matejic-Spasic, Tanja Knezevic, Biljana Zlojutro   +9 more
doaj   +1 more source

Successful Reduction of Creatine Kinase and Myoglobin Levels in Severe Rhabdomyolysis Using Extracorporeal Blood Purification (CytoSorb®) [PDF]

, 2020
Rhabdomyolysis, if severe, can lead to acute kidney injury (AKI). Myoglobin is an iron and oxygen-binding protein that is freely filtered by the glomerulus.
Ince, C. (Can), Ormskerk, P. (Patricia), Thijsse, Sjoerd, Dilken, O. (Olcay), van der Hoven, Ben; id_orcid, van der Hoven, Ben, de Geus, Hilde, Hoven, B. (Ben) van der, Dilken, Olcay, Ormskerk, Patricia, de Geus, Hilde R. H., Thijsse, S. (Sjoerd), Ince, Can, Geus, H.R.H. (Hilde) de   +13 more
core   +1 more source

Experience of using an extracorporeal cytokine hemoadsorber (CytoSorb®) in systemic inflammatory response syndrome after heart transplantation

Indian Journal of Transplantation, 2020
Heart transplantation is well-established and considered the most effective therapy for patients with end-stage heart failure. Systemic inflammatory response syndrome (SIRS) and renal dysfunction after heart transplantation are commonly experienced ...
Kewal Krishan, Rahul Dutta, Rajesh Chand, Rajneesh Malhotra   +3 more
doaj   +1 more source

Pharmacokinetics of immunosuppressive agents during hemoperfusion in a sheep model

Frontiers in Medicine, 2023
IntroductionHemoadsorption shows promising signals in organ preservation and post lung transplantation. However, its potential impact on the pharmacokinetics of immunosuppressant drugs (ID) is still unknown.MethodsIn this interventional study, CytoSorb ...
Bettina Leber, Uwe Liebchen, Lisa Rohrhofer, Jennifer Weber, Teresa Klaus, Joerg Scheier, Robert Sucher, Philipp Stiegler   +7 more
doaj   +1 more source

Supplementary Material for: Rapid and effective elimination of myoglobin with CytoSorb® hemoadsorber in patients with severe rhabdomyolysis

, 2023
Introduction: Rhabdomyolysis is characterized by destruction of muscle fibres by various causes, diagnosed by increased creatin kinase concentrations in the blood. Myoglobin released into the blood may cause acute kidney injury.
Fuchs M. (17290282), Fliser D. (4161820), Albrecht F. (17290276), Schunk S. (17290279), Meiser A. (17290291), Geisel J. (17290288), Volk T. (17290285)   +6 more
core   +1 more source

In vitro comparison of the adsorption of inflammatory mediators by blood purification devices

Intensive Care Medicine Experimental, 2018
Background Septic shock, a leading cause of acute kidney injury, induces release of pro-/anti-inflammatory mediators, leading to increased mortality and poor renal recovery.
Benjamin Malard, Corine Lambert, John A. Kellum   +2 more
doaj   +1 more source

Rapid reduction of substantially increased myoglobin and creatine kinase levels using a hemoadsorption device (CytoSorb®)—A case report

Clinical Case Reports, 2022
Rhabdomyolysis (RM) is a potentially life‐threatening entity that can lead to acute kidney injury (AKI). Continuous renal replacement therapy (CRRT) alone is known as effective therapy, but the additional use of a hemoadsorber (like CytoSorb®) might ...
Erich Moresco, Christopher Rugg, Mathias Ströhle, Matthias Thoma   +3 more
doaj   +1 more source

Cardiac arrest as a manifestation of unknown Type V glycogenosis: a case report

ESC Heart Failure, 2022
Few cases have been reported to date, in which a massive rhabdomyolysis causes a cardiac arrest in a male adult suffering from undiagnosed McArdle disease.
Raquel Soria‐Navarro, Virginia Burgos Palacios, Cristina Castrillo Bustamante, Elena Gallardo Agromayor, Sara Marcos González, Domingo González‐Lamuño Leguina   +5 more
doaj   +1 more source

Applications of Cytosorb in clinical practice

, 2021
Introduction and objective. Cytososorb is haemadsorption device approved in the European Union in 2011 for cytokine adsorption. Recently, in 2018, new indications for the device use have been added, including bilirubin and myoglobin removal.
Borys, M., Kutnik, P.
core   +1 more source